Home - Products - Others - Other Targets - 6-(4-Hydroxy-3-methylphenyl)-2-methylhept-2-en-4-one

6-(4-Hydroxy-3-methylphenyl)-2-methylhept-2-en-4-one

CAS No. 949081-05-4

6-(4-Hydroxy-3-methylphenyl)-2-methylhept-2-en-4-one( —— )

Catalog No. M31564 CAS No. 949081-05-4

6-(4-Hydroxy-3-methylphenyl)-2-methylhept-2-en-4-one is a natural product for research related to life sciences.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 1782 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    6-(4-Hydroxy-3-methylphenyl)-2-methylhept-2-en-4-one
  • Note
    Research use only, not for human use.
  • Brief Description
    6-(4-Hydroxy-3-methylphenyl)-2-methylhept-2-en-4-one is a natural product for research related to life sciences.
  • Description
    6-(4-Hydroxy-3-methylphenyl)-2-methylhept-2-en-4-one is a natural product for research related to life sciences.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    949081-05-4
  • Formula Weight
    232.32
  • Molecular Formula
    C15H20O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • HATU

    HATU is a reagent used in peptide coupling chemistry to generate an active ester from a carboxylic acid.

  • (S)-(-)-Pulegone

    (S)-(-)-Pulegone is a monoterpenoid with anti-inflammatory and anti-hyperalgesic effects.

  • MethADP

    MethADP (Adenosine 5'-(α,β-methylene)diphosphate) is a specific CD73 inhibitor that inhibits the enzyme ecto-5′-nucleotidase (ecto), which has been used in the study of neurological and cardiovascular diseases.